Notice: This company has been marked as potentially delisted and may not be actively trading. BiondVax Pharmaceuticals (BVXV) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period BiondVax Pharmaceuticals (NASDAQ: BVXV)May 8, 2024 | fool.comSCNI Scinai Immunotherapeutics Ltd.March 23, 2024 | seekingalpha.comScinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023October 4, 2023 | finance.yahoo.comScinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct OfferingSeptember 19, 2023 | finance.yahoo.comScinai Immunotherapeutics Announces $1.33 Million Registered Direct OfferingSeptember 15, 2023 | finance.yahoo.comScinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical ResultsSeptember 13, 2023 | finance.yahoo.comScinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in BostonSeptember 11, 2023 | finance.yahoo.comBiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological TherapeuticsSeptember 6, 2023 | financialpost.comBiondVax Pharmaceuticals Ltd.: BiondVax Reports Second Quarter Financial Results and Provides Business UpdateAugust 11, 2023 | finanznachrichten.deBiondVax Reports Second Quarter Financial Results and Provides Business UpdateAugust 11, 2023 | finance.yahoo.comBiondVax Pharmaceuticals Ltd.: Nasdaq Grants BiondVax Extension to Regain Compliance with Listing RulesAugust 2, 2023 | finanznachrichten.deNasdaq Grants BiondVax Extension to Regain Compliance with Listing RulesAugust 1, 2023 | finance.yahoo.comBiondVax (NASDAQ: BVXV) Leveraging NanoAb Pipeline to Target Large MarketsJuly 28, 2023 | theglobeandmail.comIBN Announces Latest Episode of The Bell2Bell Podcast featuring Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd.July 11, 2023 | finance.yahoo.comBVXV - BiondVax Pharmaceuticals Ltd.July 6, 2023 | finance.yahoo.comBiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasisJune 5, 2023 | finance.yahoo.comBVXV: Developing anti-IL-17 NanoAbMay 30, 2023 | finance.yahoo.comBiondVax Pharmaceuticals Ltd.: BiondVax Announces First Quarter 2023 Financial Results and Provides Business UpdateMay 15, 2023 | finanznachrichten.deBiondvax Pharmaceuticals GAAP EPS of $0.00 beats by $0.73May 15, 2023 | msn.comBiondVax Announces First Quarter 2023 Financial Results and Provides Business UpdateMay 15, 2023 | finance.yahoo.comBiondVax Pharmaceuticals (NASDAQ: BVXV) Leads Biotechnology Frontier with Experienced Leadership TeamApril 20, 2023 | theglobeandmail.comBiondVax Pharmaceuticals Ltd.: BiondVax Files FY 2022 Financial Statements and Annual Report on Form 10-K and Provides Business UpdateApril 18, 2023 | finanznachrichten.deBioMedNewsBreaks - BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) Lead NanoAb Candidate Holds Significant Advantages to Existing TherapiesApril 4, 2023 | marketwatch.comBioMedNewsBreaks - BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) NanoAb Holds Potential to Combat New COVID-19 VariantsMarch 26, 2023 | marketwatch.comBiondVax to Present at BIO-Europe SpringMarch 16, 2023 | finance.yahoo.comIBN Highlights 'Test. Optimize. Scale.' Episode Featuring BiondVax Pharmaceuticals Ltd. CEO Amir ReichmanMarch 6, 2023 | finance.yahoo.comIBN Announces ‘Test. Optimize. Scale.’ Interview with BiondVax Pharmaceuticals Ltd. CEO Amir Reichman Discussing De-Risked Development Pipeline and Strategic Partnerships with Premier European Research InstitutesMarch 3, 2023 | finance.yahoo.comBiondVax Presenting at BIO CEO & Investor ConferenceFebruary 2, 2023 | finance.yahoo.comBioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) NanoAb May Serve as Therapeutic and Prophylactic as Shown in Preclinical StudyJanuary 25, 2023 | benzinga.comBiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Developing Innovative Inhaled NanoAb Therapeutics for Multiple Indications, Including COVID-19January 25, 2023 | benzinga.comBiondVax Pharma: In Vivo Data Shows NanoAb Virtually Prevents COVID-19 In HamstersJanuary 23, 2023 | markets.businessinsider.comBiondVax Touts Additional Preclinical Data From Inhaled COVID-19 Treatment CandidateJanuary 23, 2023 | finance.yahoo.comBiondVax's Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo StudyJanuary 23, 2023 | it.tmcnet.comBiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo StudyJanuary 23, 2023 | finance.yahoo.comBioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) NanoAb Pipeline Targeting Large Underserved Medical NeedsJanuary 15, 2023 | benzinga.comTrading was temporarily halted for "BVXV" at 09:01 AM with a stated reason of "LULD pause."January 6, 2023 | marketbeat.comBiondVax's Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo StudyJanuary 6, 2023 | benzinga.comBiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo StudyJanuary 6, 2023 | finance.yahoo.comBiondVax to Present at Biotech Showcase 2023January 5, 2023 | finance.yahoo.comBiondVax CEO Issues Letter to ShareholdersDecember 30, 2022 | finance.yahoo.comAegis Capital Corp. Acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)December 21, 2022 | finance.yahoo.comWhy Biondvax Pharmaceuticals Stock Is Getting Obliterated During Friday's Trading SessionDecember 16, 2022 | msn.comTrading was temporarily halted for "BVXV" at 09:12 AM with a stated reason of "LULD pause."December 16, 2022 | marketbeat.comBiondVax Pharmaceuticals Ltd.: BiondVax Regains Nasdaq ComplianceDecember 13, 2022 | finanznachrichten.deIBN Announces Latest Episode of The Stock2Me Podcast featuring Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd.December 13, 2022 | finance.yahoo.comBiondVax Regains Nasdaq ComplianceDecember 12, 2022 | finance.yahoo.comBVXV: Positive Preclinical Results for Inhaled COVID-19 NanoAb…December 8, 2022 | finance.yahoo.comProfessor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory BoardDecember 6, 2022 | finance.yahoo.comIBN (InvestorBrandNetwork) Coverage Initiated for BiondVax Pharmaceuticals Ltd.December 6, 2022 | finance.yahoo.comBiondVax announces Third Quarter 2022 Financial Results and Provides Business UpdateNovember 30, 2022 | finance.yahoo.com Get BiondVax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BVXV and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide BVXV Media Mentions By Week BVXV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BVXV News Sentiment▼0.420.56▲Average Medical News Sentiment BVXV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BVXV Articles This Week▼00▲BVXV Articles Average Week Get BiondVax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BVXV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DRTSW News Today BCTXW News Today EFTRW News Today FBIOP News Today GOVXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BVXV) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiondVax Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiondVax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
